Intralymphatic Dendritic Cell Vaccination Induces Tumor Antigen–Specific, Skin-Homing T Lymphocytes
暂无分享,去创建一个
Gang Wang | Gregory Lizée | G. Wang | S. Rosenberg | P. Hwu | G. Lizée | J. Wunderlich | Steven A Rosenberg | Patrick Hwu | S. Hwang | John R Wunderlich | Amelia Grover | Grace J Kim | Mary Tschoi | Sam T Hwang | A. Grover | M. Tschoi
[1] B. Wüthrich,et al. Direct intralymphatic injection of peptide vaccines enhances immunogenicity , 2005, European journal of immunology.
[2] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[3] T. Kupper,et al. Immune surveillance in the skin: mechanisms and clinical consequences , 2004, Nature Reviews Immunology.
[4] J. Simon,et al. Dendritic Cell Immunization Route Determines CD8+ T Cell Trafficking to Inflamed Skin: Role for Tissue Microenvironment and Dendritic Cells in Establishment of T Cell-Homing Subsets1 , 2004, The Journal of Immunology.
[5] V. Cerundolo,et al. Dendritic cells: a journey from laboratory to clinic , 2004, Nature Immunology.
[6] D. Schadendorf,et al. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. , 2003, Blood.
[7] James J. Campbell,et al. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. , 2003, Blood.
[8] D. Ridgway. The First 1000 Dendritic Cell Vaccinees , 2003, Cancer investigation.
[9] L. Gardner,et al. Leukocyte extravasation: chemokine transport and presentation by the endothelium. , 2002, Blood.
[10] H. Soto,et al. CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.
[11] Eric J Kunkel,et al. Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.
[12] James J. Campbell,et al. CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed Skin , 2001, The Journal of experimental medicine.
[13] H. Tagami,et al. Molecular events occurring behind ultraviolet-induced skin inflammation , 2001, Current opinion in allergy and clinical immunology.
[14] R. Steinman,et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.
[15] Steven A. Rosenberg,et al. Progress in human tumour immunology and immunotherapy , 2001, Nature.
[16] Edgar G. Engleman,et al. Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients1 , 2001, The Journal of Immunology.
[17] P. Robbins,et al. A listing of human tumor antigens recognized by T cells , 2001, Cancer Immunology, Immunotherapy.
[18] S. Caughman,et al. Cutting Edge: C-C Chemokine Receptor 6 Is Essential for Arrest of a Subset of Memory T Cells on Activated Dermal Microvascular Endothelial Cells Under Physiologic Flow Conditions In Vitro , 2000, The Journal of Immunology.
[19] Stuart B. Goodman,et al. Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.
[20] E. Butcher,et al. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. , 2000, Current opinion in immunology.
[21] James J. Campbell,et al. Human G Protein–Coupled Receptor Gpr-9-6/Cc Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-Expressed Chemokine–Mediated Chemotaxis , 1999, The Journal of experimental medicine.
[22] Ji Ming Wang,et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .
[23] James J. Campbell,et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells , 1999, Nature.
[24] Werner Müller,et al. The Role of β7 Integrins in CD8 T Cell Trafficking During an Antiviral Immune Response , 1999, The Journal of experimental medicine.
[25] A. Mackensen,et al. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells , 1999, Cancer Immunology, Immunotherapy.
[26] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.
[27] E. Butcher,et al. Lymphocyte trafficking and regional immunity. , 1999, Advances in immunology.
[28] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[29] R. Rabin,et al. CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3a , 1998 .
[30] T. Mcclanahan,et al. CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells , 1997, The Journal of experimental medicine.
[31] H. Nomiyama,et al. Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.
[32] L L Hruza,et al. Mechanisms of UV-induced inflammation. , 1993, The Journal of investigative dermatology.
[33] R L Bartel,et al. Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone. , 1993, The Journal of investigative dermatology.
[34] L. Picker,et al. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. , 1990, The American journal of pathology.